These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 22940477

  • 1. Parkinson's disease in patients and obligate carriers of Gaucher disease.
    Becker JG, Pastores GM, Di Rocco A, Ferraris M, Graber JJ, Sathe S.
    Parkinsonism Relat Disord; 2013 Jan; 19(1):129-31. PubMed ID: 22940477
    [Abstract] [Full Text] [Related]

  • 2. Osteopontin polymorphic susceptibility factor for Parkinson's disease among patients with Gaucher disease.
    Ribner A, Altarescu G, Zimran A, Elstein D.
    Mov Disord; 2011 Jun; 26(7):1341-3. PubMed ID: 21469198
    [Abstract] [Full Text] [Related]

  • 3. Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.
    McNeill A, Magalhaes J, Shen C, Chau KY, Hughes D, Mehta A, Foltynie T, Cooper JM, Abramov AY, Gegg M, Schapira AH.
    Brain; 2014 May; 137(Pt 5):1481-95. PubMed ID: 24574503
    [Abstract] [Full Text] [Related]

  • 4. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN, Levy OA, Waters CC, Fahn S, Ford B, Kuo SH, Mazzoni P, Pauciulo MW, Nichols WC, Gan-Or Z, Rouleau GA, Chung WK, Wolf P, Oliva P, Keutzer J, Marder K, Zhang X.
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [Abstract] [Full Text] [Related]

  • 5. β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.
    Moraitou M, Hadjigeorgiou G, Monopolis I, Dardiotis E, Bozi M, Vassilatis D, Vilageliu L, Grinberg D, Xiromerisiou G, Stefanis L, Michelakakis H.
    Mol Genet Metab; 2011 Sep; 104(1-2):149-52. PubMed ID: 21745757
    [Abstract] [Full Text] [Related]

  • 6. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
    Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R.
    N Engl J Med; 2004 Nov 04; 351(19):1972-7. PubMed ID: 15525722
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations.
    Agosta F, Kostic VS, Davidovic K, Kresojević N, Sarro L, Svetel M, Stanković I, Comi G, Klein C, Filippi M.
    Mov Disord; 2013 Jun 04; 28(6):772-8. PubMed ID: 23418083
    [Abstract] [Full Text] [Related]

  • 10. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.
    Winder-Rhodes SE, Evans JR, Ban M, Mason SL, Williams-Gray CH, Foltynie T, Duran R, Mencacci NE, Sawcer SJ, Barker RA.
    Brain; 2013 Feb 04; 136(Pt 2):392-9. PubMed ID: 23413260
    [Abstract] [Full Text] [Related]

  • 11. Association between Parkinson's disease and glucocerebrosidase mutations in Brazil.
    Spitz M, Rozenberg R, Pereira Lda V, Reis Barbosa E.
    Parkinsonism Relat Disord; 2008 Feb 04; 14(1):58-62. PubMed ID: 17703984
    [Abstract] [Full Text] [Related]

  • 12. Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation.
    Aharon-Peretz J, Badarny S, Rosenbaum H, Gershoni-Baruch R.
    Neurology; 2005 Nov 08; 65(9):1460-1. PubMed ID: 16148263
    [Abstract] [Full Text] [Related]

  • 13. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
    Clark LN, Ross BM, Wang Y, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K.
    Neurology; 2007 Sep 18; 69(12):1270-7. PubMed ID: 17875915
    [Abstract] [Full Text] [Related]

  • 14. Parkinsonism among Gaucher disease carriers.
    Goker-Alpan O, Schiffmann R, LaMarca ME, Nussbaum RL, McInerney-Leo A, Sidransky E.
    J Med Genet; 2004 Dec 18; 41(12):937-40. PubMed ID: 15591280
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
    Horowitz M, Pasmanik-Chor M, Borochowitz Z, Falik-Zaccai T, Heldmann K, Carmi R, Parvari R, Beit-Or H, Goldman B, Peleg L, Levy-Lahad E, Renbaum P, Legum S, Shomrat R, Yeger H, Benbenisti D, Navon R, Dror V, Shohat M, Magal N, Navot N, Eyal N.
    Hum Mutat; 1998 Dec 18; 12(4):240-4. PubMed ID: 9744474
    [Abstract] [Full Text] [Related]

  • 16. Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease.
    Schmid SP, Schleicher ED, Cegan A, Deuschle C, Baur S, Hauser AK, Synofzik M, Srulijes K, Brockmann K, Berg D, Maetzler W.
    Mov Disord; 2012 Feb 18; 27(2):288-92. PubMed ID: 22021190
    [Abstract] [Full Text] [Related]

  • 17. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.
    Neumann J, Bras J, Deas E, O'Sullivan SS, Parkkinen L, Lachmann RH, Li A, Holton J, Guerreiro R, Paudel R, Segarane B, Singleton A, Lees A, Hardy J, Houlden H, Revesz T, Wood NW.
    Brain; 2009 Jul 18; 132(Pt 7):1783-94. PubMed ID: 19286695
    [Abstract] [Full Text] [Related]

  • 18. Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.
    Alcalay RN, Dinur T, Quinn T, Sakanaka K, Levy O, Waters C, Fahn S, Dorovski T, Chung WK, Pauciulo M, Nichols W, Rana HQ, Balwani M, Bier L, Elstein D, Zimran A.
    JAMA Neurol; 2014 Jun 18; 71(6):752-7. PubMed ID: 24756352
    [Abstract] [Full Text] [Related]

  • 19. Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.
    Shachar T, Lo Bianco C, Recchia A, Wiessner C, Raas-Rothschild A, Futerman AH.
    Mov Disord; 2011 Aug 01; 26(9):1593-604. PubMed ID: 21618611
    [Abstract] [Full Text] [Related]

  • 20. Gaucher disease: complexity in a "simple" disorder.
    Sidransky E.
    Mol Genet Metab; 2004 Aug 01; 83(1-2):6-15. PubMed ID: 15464415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.